Precision Psychiatry Using Biological Biomarkers
Discover how cutting-edge research into biological biomarkers is transforming psychiatry from traditional symptom-based diagnoses to precision medicine.
Biomarkers and Lithium Research in Mental Health Care
Meet the Research Team
- Pilot Study (PDF)
- Funding Appeal
- Meet the Researchers
- News and Announcements
- Suicide Prevention
- Lithium for Alzheimer’s
- Lithium for Addiction
Facebook
Instagram
Youtube
Twitter
Shifting Psychiatry from Symptom-Based Diagnoses to Precision Medicine Using Biological Biomarkers
On February 20, 2026, NPR’s Science Friday aired ‘Why Aren’t There Biomarkers For Mental Illness?’, highlighting one of psychiatry’s main challenges: diagnoses rely on symptoms rather than biological tests. Dr. John Krystal notes that the brain’s complexity prevents biopsies, and DSM symptom overlap complicates diagnosis. These issues underscore the vital need for actionable mental health biomarkers.
Why Aren’t There Biomarkers For Mental Illness?
The Lithium Inflammation Project (LIP) aims to shift psychiatry from symptom-based diagnoses to precision medicine using biological biomarkers. LIP examines whether inflammation drives some severe psychiatric illnesses. Specialized blood tests detect inflammation-related proteins. These early warning signs help find patients likely to benefit from targeted treatments. This approach creates clearer diagnoses and treatments tailored to biology, not just symptoms. We identify these patients, track changes, and link inflammation markers to clinical progress.
Why focus on lithium? Lithium bridges psychiatry, neurology, and the biology of inflammation. Its unique mood-stabilizing effects and proven suicide risk reduction set it apart. Lithium regulates GSK-3 and affects both brain function and inflammation. It is affordable, accessible, and safe at low doses. These qualities make lithium ideal for studying whether low-dose supplementation can improve outcomes and affect inflammatory biomarkers.
Take Decisive Action Now
Become a key partner in pioneering the first inflammation-guided treatment plan. Your immediate support will drive transformative, personalized care and accelerate breakthrough biomarker research, bringing new hope and outcomes for patients in need. Your contribution accelerates research by funding data collection, patient outreach, and the use of advanced biomarker tools in routine care. Specifically, a $500 donation processes five blood samples with biomarker analysis, enabling the identification and monitoring of key inflammation markers for patient care.
Donate today to fuel progress in inflammation-informed psychiatry. Every dollar directly delivers innovative, targeted care and real hope—your support makes a lasting, life-changing difference now.
LIP Study News & Announcements
Read the Lithium Inflammation Psychiatry (LIP) Study (PDF)
A Double-Blind, Placebo-Controlled, Crossover Study.
Health Effects of Low-Dose Lithium: A Systematic Review
See the latest Articles and Posts about the LIP Study.
Mental Health & Low-Dose Lithium
Low-Dose Lithium Research Team from the Karolinska Institute
Personality Disorder Research Team from the Karolinska Institute
News Archives